Holds one active US DMF and 2 valid CEPs for atenolol, filing since 2000. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and one valid CEP for atenolol, filing since 1999. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for atenolol, filing since 2018. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for atenolol, filing since 1987.
Registered with PMDA (Japan) for atenolol.
Registered with DAV (Vietnam) for atenolol. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for atenolol. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free| Year | Median | Exporters |
|---|---|---|
| 2026 YTD | $22.53 | 11 |
| 2025 | $24.31 | 35 |
| 2024 | $24.64 | 31 |
| 2023 | $26.00 | 28 |
US dollars per kilogram, customs export unit values.